Pharma Journalist - Page 845 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Tubilux Selects TraceLink to Achieve EU FMD Compliance

NewLink Genetics to evaluate IO-Based Combination Therapies in Pancreatic Cancer

AstraZeneca announces positive top-line results of Phase III, PINNACLE 4 trial

Genelux Initiates Phase 2 Clinical Trial of GL-ONC1 in Recurrent Ovarian Cancer

EC approves Symtuza for the Treatment of HIV-1 in Adults and Adolescents in Europe

Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin

Medherant Signs Agreement with Leading Japanese Transdermal Patch Company

Amgen and Simcere to Co-Develop and Commercialize Biosimilars In China

Teva Announces Reintroduction of Generic Depo-Provera in the United States

CFDA approves Gilead’s Sovaldi for Treatment of Chronic Hepatitis C Virus Infection